Clinical Trial Update: Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer [NA]

View source ↗

Summary

A clinical trial update describes a study of transurethral resection of bladder tumor followed by adjuvant intravenous gemcitabine/cisplatin chemotherapy for no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Epirubicin (epirubicin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Bladder Cancer, Gemcitabine and Cisplatin Chemotherapy | NA | Status: UNKNOWN